This Week In Cannabis: Gaetz's Stock Rally, Major Policy Battles, Homeland Security's Stance, Big Earnings And More
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 28 2025
0mins
Source: Benzinga
Regulatory Developments: Florida's appeals court upheld a $1.3 million medical cannabis license renewal fee, while Virginia's Governor vetoed a cannabis sales bill for the second time, delaying the state's market launch. New York expanded its cannabis farmers market program to support licensed businesses amidst ongoing regulatory challenges.
Market Trends and Business Updates: Cannabis sales in Canada dropped 14.9% in January, while Ohio's cannabis industry surpassed $2.5 billion in total sales. Companies like Planet 13 and iAnthus reported revenue growth but also faced net losses, highlighting the volatility and evolving landscape of the cannabis market.
Analyst Views on TLRY
Wall Street analysts forecast TLRY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TLRY is 9.57 USD with a low forecast of 8.50 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
1 Buy
3 Hold
0 Sell
Hold
Current: 9.130
Low
8.50
Averages
9.57
High
10.00
Current: 9.130
Low
8.50
Averages
9.57
High
10.00
About TLRY
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
